All News
|
Research Feature
Joncita Todechine, a mother of four who lives on the Navajo Nation, knows all too well what can trigger asthma symptoms in her daughter Ashley. But she didn’t always. She recalls a time in 2013, living in Phoenix and attending medical assistant school, when she rushed her then-three-year-old to the Indian Medical Center. “She was really sick,”...
Showing 10 out of 114 results
|
NHLBI in the Press
Sleep apnea, a condition characterized by disrupted breathing during sleep, appears to be a risk factor for more severe outcomes in patients with COVID-19, according to a study published in the American Journal of Respiratory and Critical Care Medicine.
|
Research Feature
Months ago, when news came flooding in about the dire toll the novel coronavirus can take on the body, so did the phone calls to Beth Kozel, M.D., Ph.D. A clinical geneticist in the Division of Intramural Research (DIR) at the National Heart, Lung, and Blood Institute (NHLBI), Kozel cares for adult and pediatric patients with rare connective tissue...
|
News Release
Los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) anunciaron hoy una subvención de $12 millones para proyectos de promoción de salud y participación comunitaria en regiones con minorías étnicas y raciales afectadas de manera desproporcionada por la pandemia de COVID-19. Con estos fondos, RTI International, una institución de...
|
News Release
The National Institutes of Health today announced a $12 million award for outreach and engagement efforts in ethnic and racial minority communities disproportionately affected by the COVID-19 pandemic. The award to RTI International, a non-profit research institution, will support teams in 11 states established as part of the NIH Community...
|
NHLBI in the Press
Communities in Massachusetts with a higher proportion of Black and Latino residents have higher COVID-19 case rates, according to a study in Health Affairs. The analysis suggests tailoring public health responses for communities disproportionally affected by the pandemic.
|
News Release
The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100...
|
NHLBI in the Press
The National Institutes of Health launched two of three clinical trials to test the safety and effectiveness of various blood thinners to treat patients who are hospitalized with COVID-19 and those with COVID-19 who do not require hospitalization.
|
Research Feature
Researchers supported by the National Institutes of Health have launched a key study to explore the safety and effectiveness of convalescent plasma in treating patients who have recently (within the last week) developed mild to moderate symptoms of COVID-19 disease. The study, which focuses on patients not yet hospitalized, comes on the heels of an...
|
Research Feature
As the coronavirus pandemic continues to disrupt daily living, researchers are taking a closer look at one requirement for health that many people take for granted: sleep. And they’ve concluded, perhaps not surprisingly, that improving our sleep schedule and quality is an important part of coping with these stressful times and defending against...
|
NHLBI in the Press
Young people who were tested for COVID-19 and vaped were five to seven times more likely to be infected than those who did not use e-cigarettes, according to new findings published in the Journal of Adolescent Health.